Home Health PanGenomic Health Issues Letter to Shareholders

PanGenomic Health Issues Letter to Shareholders

0
PanGenomic Health Issues Letter to Shareholders

[ad_1]

VANCOUVER, BC, Dec. 22, 2022 /CNW/ – PanGenomic Health Inc. (“PanGenomic” or the “Company”) (CSE: NARA) in the present day issued a letter to shareholders from its government staff.

Dear Shareholders,

As we shut out our first 12 months as a publicly-traded firm, your staff at PanGenomic Health is busy laying the groundwork for fulfillment within the burgeoning well being know-how trade. 

At the core of our evidence-based well being platform is an structure that places the person in command of their psychological well being. Our personalised perception system helps folks determine various pure treatments for frequent circumstances and optimizations for the thoughts and physique. Users also can join on-line with a circle of trusted well being practitioners, akin to medical docs, naturopaths, therapists, herbalists and nutritionists.

Mental Health

The rise of psychological well being challenges from the COVID-19 pandemic can’t be overstated. In 2022, we continued to see the normal medical group grappling to satisfy the rising demand for companies to assist people take care of normal temper circumstances, akin to anxiousness and melancholy. Pharmaceutical medication and traditional drugs play an essential position, nevertheless, there are evidence-based options which are therapeutically helpful as nicely. There is critical shopper curiosity in therapeutic therapeutic choices, akin to plant-based pure treatments, psychotherapy, behavioural conditioning instruments and academic self-guided packages with consumer-friendly know-how.

Investments within the behavioural well being trade in 2021 had been at a document excessive, and investments this 12 months are on monitor to be the second highest on document. From Amazon’s $3.9 billion acquisition of One Medical to Headspace’s acquisitions of Sayana and Shine, the well being know-how trade has demonstrated that technology-driven well being options for the fashionable shopper are in demand.

Natural Solutions

While psychological well being circumstances are on the rise, there’s additionally growing shopper curiosity in pure treatments as a substitute for pharmaceutical drug therapies. Health-conscious customers within the West are gaining better publicity to inexpensive and accessible natural treatments utilized in centuries-old therapeutic practices, akin to Ayurvedic Medicine and Traditional Chinese Medicine. Health regulators, akin to Health Canada and the U.S. Food & Drug Administration, have eased the approval processes for pure well being merchandise and botanical medication, as inspired by the World Health Organization’s Traditional Medicine Strategy.

Global meals and drug firms continued to put money into the pure treatment trade this 12 months, as demonstrated by Nestle’s majority stake funding in Orgain, a $2 billion plant-based diet dietary supplements producer, and Jamieson Wellness’ acquisition of premium complement producer Nutrawise for over $200 million.

Personalized Medicine

Finding the proper pure treatment therapies for psychological well being circumstances has its challenges, given the individuality of every particular person. The area of personalised or precision drugs seeks to tailor therapies that keep in mind variations in folks’s genes, environments, and life. While pharmacogenomics could assist determine the proper pharmaceutical drug to work nicely for an individual’s distinctive DNA, nutrigenomics can present how a person’s genetic make-up could have an effect on whether or not a specific meals advantages well being and wellness.

With final 12 months’s acquisition by 23andMe of telehealth platform firm Lemonaid Health for $400 million, we imagine there’ll proceed to be important market alternatives for built-in genetic testing and shopper digital well being options on account of elevated shopper curiosity and scientific proof.

Product Suite

Given the rise in psychological well being circumstances and the curiosity in pure and various therapies, we imagine there’s a important market alternative for a self-care platform that helps folks discover the proper pure treatment for his or her explicit psychological well being situation. Our PanGenomic platform has been designed to generate income from particular person or bundled merchandise by way of a mix of subscription-based pricing and one-time charges.

Our shopper app Nara and accompanying nara.care web site curate pure treatments for people, and customers will probably be charged subscription charges to entry premium content material. Our medical determination help platform PlantGx helps monitor the efficacy of remedy packages utilizing our proprietary biomarker panel, aiding well being practitioners to optimize regimens for higher affected person outcomes. Health practitioners will probably be charged for entry to premium content material and diagnostic checks by way of subscription and one-time charges. Both of our Nara and PlantGx merchandise leverage genetic take a look at outcomes from 23andMe and Ancestry shopper DNA checks.

With our latest acquisition of Mindleap Health and its telehealth platform, we’re excited to increase our attain to customers and well being practitioners wishing to study psychedelic-assisted therapies for remedy of psychological well being circumstances, akin to melancholy and post-traumatic stress problems.

Benefit Corporation

As one among Canada’s first publicly-traded profit companies, we imagine that the attain of the capital markets might be expanded to new retail traders who wish to help companies that pursue revenue and social function. Our deal with income technology in 2023 from our new suite of merchandise for customers and well being practitioners will probably be guided by our mandate as a profit company to enhance the well being and wellness of individuals by way of progressive know-how.

Finally, we want to thank all of our shareholders for his or her valued help of our mission to assist folks with their psychological wellness journeys.

Regards,

Maryam Marissen                                                                                                      
President & CEO

Vincent Lum
Co-Founder and
CEO, PlantGx Diagnostics Corp.

Robert Nygren
Co-Founder and Executive Chair

About PanGenomic Health

PanGenomic Health is a precision well being firm that has developed a self-care digital platform to ship personalised, evidence-based details about pure therapies. The Company’s preliminary focus is to help psychological well being. Registered as a British Columbia profit firm, PanGenomic Health’s mission is to advertise and enhance the well being and wellness of individuals and society by offering a know-how platform that identifies plant-based options tailor-made to the well being profile of every particular person.

This information launch consists of sure statements which may be deemed “forward-looking statements”, together with statements respecting the companies to be offered by PanGenomic and the consideration to be paid to PanGenomic. The use of any of the phrases “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and comparable expressions are meant to determine ahead trying statements. Although PanGenomic believes that the expectations and assumptions on which the forward-looking statements are primarily based are affordable, undue reliance shouldn’t be positioned on the forward-looking statements as a result of PanGenomic can provide no assurance that they’ll show to be appropriate. Since forward-looking statements tackle future occasions and circumstances, by their very nature they contain inherent dangers and uncertainties. These statements communicate solely as of the date of this News Release. Actual outcomes may differ materially from these at present anticipated on account of a variety of elements and dangers together with numerous danger elements mentioned in PanGenomic’s disclosure paperwork which might be discovered below PanGenomic’s profile on www.sedar.com.

The Canadian Securities Exchange has neither accredited nor disapproved the knowledge contained herein and doesn’t settle for duty for the adequacy or accuracy of this information launch.

SOURCE PanGenomic Health Inc.

For additional info: Jerry Lai, Investor Relations, PanGenomic Health Inc., 778 743 4642, [email protected]; Maryam Marissen, President & CEO, PanGenomic Health Inc., 778 743 4642, [email protected]

[adinserter block=”4″]

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here